INVO Fertility, Inc. (Formerly Emy's Salsa Aji Distribution Company, Inc.) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed on December 29, 2008, by Emy's Salsa Aji Distribution Company, Inc. The report details a fundamental corporate restructuring, including a name change to INVO Bioscience, Inc., effective upon filing with the Nevada Secretary of State.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and structural amendments rather than financial performance.
Material Changes
- Corporate Name: Changed from Emy's Salsa Aji Distribution Company, Inc. to INVO Bioscience, Inc.
- Capital Structure: Authorized common stock increased from 75,000,000 to 200,000,000 shares. Additionally, 100,000,000 shares of undesignated preferred stock were created.
- Stock Identification: The CUSIP number for common stock will change to 44984F 104. The trading symbol on the Over-the-Counter Bulletin Board is expected to change from "EMYS" to "INVO."
- Directors' Liability: New provisions eliminate director liability for monetary damages to the fullest extent permitted by Nevada law, except in cases of intentional misconduct, fraud, or knowing violation of law.
- Indemnification: Officers and directors are indemnified to the fullest extent permitted by Nevada law, with protections remaining effective for actions occurring prior to any future amendments.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future financial guidance, operational outlook, or specific business risks. The primary contingency noted is the administrative process of updating the trading symbol and CUSIP number with the relevant exchanges and clearing houses.
Key Facts for Investor Verification
- Verify the new trading symbol "INVO" and CUSIP "44984F 104" on the Over-the-Counter Bulletin Board.
- Confirm the approval of the Restated Articles by holders of 58.4% of outstanding common stock as of December 22, 2008.
- Review the attached Exhibit 3.1 (Amended and Restated Articles of Incorporation) for full legal text regarding the new capital structure and liability limitations.
- Note the significant increase in authorized common shares (from 75M to 200M) and the creation of a new preferred stock class, which may impact future dilution.